Progestins and endometrium;Gestagene und Endometrium

Zentralblatt fur Gynakologie

Volumn 119, Issue SUPPL. 2, 1997, Pages 59-63

  Schindler, A E ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Endometrial hyperplasia; Endometrium; Estrogens; Progesterone; Progestins

Indexed keywords

ESTROGEN; GESTAGEN; GLUTATHIONE PEROXIDASE; PROGESTERONE; PROGESTERONE RECEPTOR; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

DECIDUALIZATION; ENDOMETRIUM; ENZYME ACTIVITY; HUMAN; MITOSIS INHIBITION; NIDATION; REVIEW;

CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; EMBRYO IMPLANTATION; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; PREGNANCY; PROGESTERONE; PROGESTERONE CONGENERS; PROGESTINS;

EID: 0030709228     PISSN: 00444197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Affinito P, Di Carlo C, Di Mauro P, Napolitano V, Nappi C: Endometrial hyperplasia: efficacy of a new treatment with a vaginal cream containing natural micronized progesterone. Maturitas 20 (1994 191-198
2. Boerrigter PJ, van de Weijer PHM, Baak JPA, Fox H, Haspels AA, Kenemans P: Endometrial response in estrogen replacement therapy quarterly combined with a progestogen. Maturitas 24 (1996) 63-71
3. Bohnet HG, Bertram M: Die perioperative Hormonbehandlung bei perimenopausalen Patientinnen mit gutartigen Veränderungen und ihre Beeinflußbarkeit durch verschiedene Hormontherapien. Gynäkologe 22 (1989) 255-260
4. Burch DJ, Spowart KJM, Jesinger DK, Randall S, Smith SK: A dose-raning study of the use of cyclical dydrogesterone with continous 17β oestradiol. Brit J Obstet Gynaecol 102 (1995) 243-248
5. Dallenbach-Hellweg G: Konservative organerhaltende Maßnahmen bei Vorstadien des Endometriumkarzinoms. Gynäkologe 21 (1988) 302-307
6. Dessesford SAA, Weis NS, Foith LF, Me Night B: Risk of endometrium cancer in relation in use of estrogen combined with cyclic progestin therapy in postmenopausal women. Lancet 349 (1997) 458-461
7. Fujimoto M, Kanzaki H, Nakayama H, Higuchi T, Hatayama H, Iwai M, Kaneko Y, Mori T, Jujita J: Requirement for transglutaminase in progesterone-induced decidualization of human endometrial cells. Endocrinol 137 (1996) 1096-1101
8. Gal D, Edman CD, Vellios VF, Forney JP: Long-term effect of megestrol acetate in the treatment of endometrial hyperplasia. Am J Obstet Gynecol 146 (1983) 316-322
9. Gambrell RD, Udoff LC, Adashi EY: Combined continous hormone replacement therapy: Critical review, Obstet Gynecol 86 (1995) 869-870
10. Grady D, Gebrazadik D, Kellikowsky K, Ernst AV, Batiti D: Hormon replacement therapy and endometrial cancer risk: A metanasis. Obstet Gynecol 85 (1995) 304-313
11. Griesinger R, Schindler AE: Therapie mit Gestagenen bei hyperplastischen Veränderungen des Endometriums. Geburtshilfe u. Frauenheilkunde 46 (1986) 690-692
12. Iruela-Arispe ML, Porter P, Bornstein P, Sage EH: Throm-bospondin-1, an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium. J Clin Invest 97 (1996) 403-412
13. Judd HL (The writing group for the PEPI trial): Effect of hormone replacement therapy on endometrial histology in postmenopausal women. JAMA 275 (1996) 370-375
14. Kim S, Korhonen, Wilborn W, Foldesy R, Snipes W, Hodgen GD, Anderson RD: Antiproliferative effects of low-dose micronized progesterone. Fertil Steril 65 (1996) 323-331
15. Klinger G: Gestagene und Hormonsubstitution. Zentralbl Gynakol 117 (1995) 25-29
16. Lessey BA, Ilesanmi AO, YEH 1, Korzeniowski P, Castelbaum AJ, Sun J, Fritz MA, Chwalisz K: Endometrial progesterone receptors and markers of uterine receptivity in the window of implantation. Fertil Steril 65 (1996) 477-483
17. Lindahl B, Willen R: Endometrial hyperplasia following estrogen treatment without the addition of gestagen. A follw-up study after withdrawal of estrogens. Anticancer Res 11 (1991) 2071-2073
18. Lindgren R, Risberg B, Hammar M, Berg G: Transdermal hormonal replacement therapy with transdermal progestin every second month. Maturitas 22 (1995) 25-30
19. McConigl F, Kalan BY, Marbuto DA, Leuchter RS, Lagasse LD, Judd HL: Development of endometrial cancer in women on estrogen and progestin hormonal replacement therapy. Gynecol Oncol 55 (1994)126-132
20. Nand SL, Webster MA, Wren BG: Continuous combined piperazine oestrone sulphate and medroxyprogesterone acetate hormone replacement therapy - A study of bleeding pattern, endometrial responce, serum lipid and bone density changes. Aust NZ J Obstet Gynaecol 35 (1995) 92-96
21. Ohwada M, Suzuki M, Sato I, Tsukamoto H, Watanabe K: Glutathione peroxidase activity in endometrium: Effects of sex hormones and cancer. Gynecol Oncol 60 (1996) 277-282
22. Orlandi C, Martinelli G, Marabini A: Treatment of endometrial hyperplasia with progestins: comparison between medroxyprogesterone acetate and cyproterone acetate. Gynecol Endocrinol 1 (1985) 25-29
23. Paterson MEL, Wade-Evans T, Sturcke DW, Thorn MH, Studd JWW; Endometrial disease after treatment with estrogens and progestins in the climacteric. Brit Med J 1 (1980) 822-824
24. Schacter L, Rozencweig M, Canetta R, Kelley S, Nicaise C, Smaldone L: Megestrol acetate: Clinical experience. Cancer Treatm Reviews 16 (1989) 49-63
25. Schweppe K-W: Die Bedeutung der Gestagene zur Behandlung der Endometriose. Zentralbl Gynakol 119 (1997) Suppl 2, 64-69
26. Seppälä M, Koistinen R, Rutanen EM: Uterine endocrinology and paracrinology: insulin-like growth binding protein-1 and placental protein 14 revisited. Human Reprod 9 (1994) Suppl 2, 96-106
27. Shoupe D, Meme D, Mezrow G, Lobo RA: Prevention of endometrial hyperplasia in postmenopausal women with intrauterine progesterone. N Engl J Med 325 (1991) 1811-1812
28. Song JY, Russell P, Markham R, Manconi F, Fraser IS: Ef- feet of high dose progestogens on white cells and necrosis in human endometrium. Human Reproduct 11 (1996) 1713-1718
29. Sturdee DW: Endometrial morphology and bleeding patterns as a function of progestogen supplementation. Int J Fertil (1996) 22-28
30. Suhonen S, Lähteenmäki P, Haukkamaa M, Rutanen EM, Holmström T: Endometrial response to hormone replacement therapy as assessed by expression of insulin-like growth factor-binding protein-1 in the endometrium. Fertil Steril 65 (1996) 776-782
31. Sutherland RL, Lee CSL, Cornish AL, Musgrove EA: Progestin regulation of cell proliferation in the breast and endometrium. In: Organ-Selective Actions of Steroid Hormones. Ernst Schering Research Foundation Workshop 16. Eds: Baird DT, Schütz G, Krattenmacher R, Berlin - Heidelberg: Springer 1995, 85-105
32. Whitehead MI, Fraser D: Controversies concerning the safety of estrogen replacement therapy. Am J Obstet Gynecol 156 (1987) 1313-1322
33. Woodruff JD, Pickar JH: Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. Amer J Obstet Gynecol 170 (1994) 1213-1223